Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oasis Consumer Healthcare is a Cleveland-based consumer health company that specializes in developing innovative oral care and infection prevention products. Founded in 2010 by Afif Ghannoum and Brian Sokol, the company acquired the Oasis dry mouth brand and subsequently developed Halo, a first-of-its-kind oral antiseptic spray that creates a microbial barrier to protect against airborne germs. The company's research-driven approach led to the spin-off of ARMS Pharmaceutical, which focuses on the clinical development of its barrier technology for preventing respiratory infections like influenza and COVID-19. Oasis Consumer Healthcare's products are sold in major retail chains across the United States, leveraging a virtual business model and partnerships with leading medical institutions in Cleveland. The company's core technology utilizes a combination of antiseptic agents and barrier-forming polymers to provide sustained protection against pathogens.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oasis Consumer Healthcare.